top of page
Home > Case Studies > Academic Research & Quantitative Analysis
ACADEMIC JOURNAL ARTICLE
PHARMACEUTICALS & CANCER
NHS AND PUBLIC HEALTH LEADERS
Janssen are the pharmaceutical companies of J&J, the largest pharmaceutical company in the world by revenue. As part of their Diversity & Inclusion strategy the UK and Ireland division commissioned Interpretive Economics to produce an academic-level research report into the relationship between ethnicity and cancer patient care in England using a unique NHS patient dataset.
The project involved an in-depth review of the academic literature relating to cancer and ethnicity and rigorous statistical analysis of national and regional patient activity indicators, including the development of multi-variate linear regression models. The analysis was published in a peer-reviewed journal, Archives of Clinical and Biomedical Research.
The three core findings - that ethnic minority patients have higher average clinical severity, higher treatment costs and were disproportionately negatively impacted by COVID-19 allowed Janssen to engage senior NHS and Department of Health decision makers in meaningful policy discussions.
Read the article here..
bottom of page